Capecitabine-based chemotherapy in early-stage triple-negative breast cancer: a meta-analysis

INTRODUCTION: The efficacy and safety of adjuvant capecitabine in early-stage triple-negative breast cancer remains undefined. A meta-analysis was conducted to elucidate whether capecitabine-based regimens could improve survival in early-stage triple-negative breast cancer (TNBC). METHODS: The curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Jie, Yao, Xufeng, Pu, Yinghong, Wang, Xiaoyi, Luo, Xinrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634425/
https://www.ncbi.nlm.nih.gov/pubmed/37954087
http://dx.doi.org/10.3389/fonc.2023.1245650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634425/
https://www.ncbi.nlm.nih.gov/pubmed/37954087
http://dx.doi.org/10.3389/fonc.2023.1245650

Ejemplares similares